Related Experiment Video
Updated: May 5, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Neural correlates of cognitive decline in older adults at-risk for developing MCI: evidence from the CDA and P300
Rachel N Newsome1, Carson Pun, Victoria M Smith
1a Department of Psychology , University of Toronto , Toronto , Canada.
Abstract:
Improving the ability to detect Alzheimer's disease (AD) at the earliest stages is essential to effectively treat afflicted individuals. Electrophysiological signatures are a promising avenue for earlier diagnosis. In the present study, we investigated an ERP component associated with visual working memory capacity, the contralateral delay activity (CDA). Our participants were undiagnosed and supposedly healthy members of the community, but were defined to be at-risk for Mild Cognitive Impairment (MCI) based on performance from a brief, standardized neuropsychological test. We found that older adults at-risk for MCI had a reduced visual working memory capacity and reduced differentiation of the CDA. In a second experiment, we found that the P300, a well-characterized ERP component shown to be useful in determining conversion from MCI to AD, showed reduced amplitude in our at-risk group. Together, these findings suggest that electrophysiological signatures may be especially sensitive markers of the very earliest stages of AD.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Cognitive Development During Adulthood
Alzheimer Disease l: Introduction
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Role of Cerebellum and Prefrontal Cortex in Memory
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists